Free Shipping on purchases over €100

Cumediet Artimusc Forte , 20 sobres

Cumediet Artimusc Forte , 20 sachets

Cumediet Artimusc Forte is a blend of natural components aimed at improving damaged joints, as well as relieving discomfort within minutes of ingestion. It contains devil's claw, which acts as a natural analgesic, as well as hydrolysed collagen and MSM.

SKU: CU8435232729016
-19%
Promo FD
22.70
€28.19

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Artimusc Forte is produced by Cumediet from a formula that focuses on joint comfort and cartilage regeneration. To this end, it has used the analgesic properties of devil's claw, a medicinal plant that helps relieve pain without causing side effects.

It also contains hydrolysed collagen of porcine origin, which is rapidly absorbed and used by the body to accelerate tissue regeneration. It is also optimised with vitamin C, which is necessary for the synthesis of collagen, as well as protecting it so that the body uses as much as possible. In this way, it promotes the repair of broken cartilage to alleviate discomfort in the medium and long term, as well as improving the flexibility of tendons and ligaments.

Cumediet has also added marine polysaccharides that stimulate the body's ability to produce collagen to prevent recurrent recurrence of the condition. This is supported by the silicon found in bamboo and horsetail, as well as the antioxidant properties of vitamin C, which protects cells.

In addition, magnesium helps to relax the muscles to relieve contractures caused by the accumulation of stress, as well as excessive physical activity.

All this is intended to improve the body's flexibility and overall mobility.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.